S&P 500   3,145.91 (+0.91%)
DOW   28,015.06 (+1.22%)
QQQ   205.00 (+1.07%)
AAPL   270.71 (+1.93%)
FB   201.05 (+0.85%)
MSFT   151.75 (+1.21%)
GOOGL   1,339.39 (+0.94%)
AMZN   1,751.60 (+0.64%)
CGC   18.65 (+0.27%)
NVDA   212.17 (+1.64%)
MU   47.93 (+2.81%)
BABA   201.89 (+0.95%)
GE   11.10 (+2.87%)
TSLA   335.89 (+1.67%)
T   38.20 (+0.03%)
AMD   39.63 (+0.03%)
ACB   2.43 (-0.41%)
F   9.02 (+1.01%)
PRI   135.68 (+1.03%)
NFLX   307.35 (+1.48%)
BAC   33.67 (+1.75%)
GILD   67.08 (+1.74%)
DIS   147.66 (+0.15%)
S&P 500   3,145.91 (+0.91%)
DOW   28,015.06 (+1.22%)
QQQ   205.00 (+1.07%)
AAPL   270.71 (+1.93%)
FB   201.05 (+0.85%)
MSFT   151.75 (+1.21%)
GOOGL   1,339.39 (+0.94%)
AMZN   1,751.60 (+0.64%)
CGC   18.65 (+0.27%)
NVDA   212.17 (+1.64%)
MU   47.93 (+2.81%)
BABA   201.89 (+0.95%)
GE   11.10 (+2.87%)
TSLA   335.89 (+1.67%)
T   38.20 (+0.03%)
AMD   39.63 (+0.03%)
ACB   2.43 (-0.41%)
F   9.02 (+1.01%)
PRI   135.68 (+1.03%)
NFLX   307.35 (+1.48%)
BAC   33.67 (+1.75%)
GILD   67.08 (+1.74%)
DIS   147.66 (+0.15%)
S&P 500   3,145.91 (+0.91%)
DOW   28,015.06 (+1.22%)
QQQ   205.00 (+1.07%)
AAPL   270.71 (+1.93%)
FB   201.05 (+0.85%)
MSFT   151.75 (+1.21%)
GOOGL   1,339.39 (+0.94%)
AMZN   1,751.60 (+0.64%)
CGC   18.65 (+0.27%)
NVDA   212.17 (+1.64%)
MU   47.93 (+2.81%)
BABA   201.89 (+0.95%)
GE   11.10 (+2.87%)
TSLA   335.89 (+1.67%)
T   38.20 (+0.03%)
AMD   39.63 (+0.03%)
ACB   2.43 (-0.41%)
F   9.02 (+1.01%)
PRI   135.68 (+1.03%)
NFLX   307.35 (+1.48%)
BAC   33.67 (+1.75%)
GILD   67.08 (+1.74%)
DIS   147.66 (+0.15%)
S&P 500   3,145.91 (+0.91%)
DOW   28,015.06 (+1.22%)
QQQ   205.00 (+1.07%)
AAPL   270.71 (+1.93%)
FB   201.05 (+0.85%)
MSFT   151.75 (+1.21%)
GOOGL   1,339.39 (+0.94%)
AMZN   1,751.60 (+0.64%)
CGC   18.65 (+0.27%)
NVDA   212.17 (+1.64%)
MU   47.93 (+2.81%)
BABA   201.89 (+0.95%)
GE   11.10 (+2.87%)
TSLA   335.89 (+1.67%)
T   38.20 (+0.03%)
AMD   39.63 (+0.03%)
ACB   2.43 (-0.41%)
F   9.02 (+1.01%)
PRI   135.68 (+1.03%)
NFLX   307.35 (+1.48%)
BAC   33.67 (+1.75%)
GILD   67.08 (+1.74%)
DIS   147.66 (+0.15%)
Log in

NASDAQ:MDAS - MedAssets Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$31.35
0.00 (0.00 %)
(As of 01/28/2016)
Add
Today's Range
$31.35
Now: $31.35
$31.35
50-Day Range N/A
52-Week Range
$17.00
Now: $31.35
$31.35
VolumeN/A
Average Volume1.79 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
MedAssets, Inc (MedAssets) provides technology-enabled products and services to healthcare organizations, including hospitals, health systems, non-acute healthcare providers, payers, other service providers and product manufacturers. The Company operates its business through two business segments: Spend and Clinical Resource Management (SCM) and Revenue Cycle Management (RCM). Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Technology
SectorN/A
Current SymbolNASDAQ:MDAS
CUSIP58404510
Phone+1-678-3232500

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive MDAS News and Ratings via Email

Sign-up to receive the latest news and ratings for MDAS and its competitors with MarketBeat's FREE daily newsletter.


MedAssets (NASDAQ:MDAS) Frequently Asked Questions

What is MedAssets' stock symbol?

MedAssets trades on the NASDAQ under the ticker symbol "MDAS."

How were MedAssets' earnings last quarter?

MedAssets, Inc. (NASDAQ:MDAS) posted its earnings results on Wednesday, July, 29th. The technology company reported $0.31 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.27 by $0.04. The technology company had revenue of $190.40 million for the quarter, compared to the consensus estimate of $187.45 million. MedAssets's quarterly revenue was up 8.6% compared to the same quarter last year. During the same quarter last year, the business earned $0.30 EPS. View MedAssets' Earnings History.

Has MedAssets been receiving favorable news coverage?

News stories about MDAS stock have been trending very positive this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. MedAssets earned a media sentiment score of 4.0 on InfoTrie's scale. They also assigned media stories about the technology company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for MedAssets.

Who are some of MedAssets' key competitors?

What other stocks do shareholders of MedAssets own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MedAssets investors own include CVS Health (CVS), StoneMor Partners (STON), QUALCOMM (QCOM), Chesapeake Energy (CHK), Chevron (CVX), Corecivic (CXW), Freeport-McMoRan (FCX), Corning (GLW), Schlumberger (SLB) and AT&T (T).

What is MedAssets' stock price today?

One share of MDAS stock can currently be purchased for approximately $31.35.

What is MedAssets' official website?

The official website for MedAssets is http://www.medassets.com/.

How can I contact MedAssets?

MedAssets' mailing address is 100 N Point Ctr E Ste 200, ALPHARETTA, GA 30022-8261, United States. The technology company can be reached via phone at +1-678-3232500.


MarketBeat Community Rating for MedAssets (NASDAQ MDAS)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  293 (Vote Outperform)
Underperform Votes:  334 (Vote Underperform)
Total Votes:  627
MarketBeat's community ratings are surveys of what our community members think about MedAssets and other stocks. Vote "Outperform" if you believe MDAS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDAS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/6/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel